CompletedPhase 2NCT00817180
Long-term Study, Comparing Vest Therapy to Positive Expiratory Pressure (PEP) Therapy in the Treatment of Cystic Fibrosis
Studying Cystic fibrosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of British Columbia
- Principal Investigator
- Maggie McIlwaine, PhysioBC Children's Hospital, Vancouver
- Intervention
- Positive Expiratory Pressure (PEP)(other)
- Enrollment
- 107 enrolled
- Eligibility
- 6 years · All sexes
- Timeline
- 2008 – 2012
Study locations (13)
- Foothills Medical Centre, Calgary, Alberta, Canada
- Alberta Children's Hospital, Edmonton, Alberta, Canada
- University of Alberta Hospitals, Edmonton, Alberta, Canada
- BC Children's Hospital, Vancouver, British Columbia, Canada
- St. Paul's Hospital, Vancouver, British Columbia, Canada
- Children's Hospital of Winnipeg, Winnipeg, Manitoba, Canada
- St. Clare's Mercy Hospital, St. John's, Newfoundland and Labrador, Canada
- Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada
- Ottawa General Hospital, Ottawa, Ontario, Canada
- The Hospital for Sick Children, Toronto, Toronto, Ontario, Canada
- Montreal Children's Hospital, Montreal, Quebec, Canada
- CHU Ste-Justine, Montreal, Quebec, Canada
- Centre Mere-Enfant du CHUQ, Québec, Quebec, Canada
Collaborators
Canadian Cystic Fibrosis Foundation
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00817180 on ClinicalTrials.govOther trials for Cystic fibrosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT04530383Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel FunctionUniversity of Kansas Medical Center
- RECRUITINGPHASE2NCT07450547Phase 2 Study to Assess the Safety and Efficacy of ANG003Anagram Therapeutics, Inc.
- RECRUITINGPHASE1NCT07437105Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy ParticipantsVertex Pharmaceuticals Incorporated
- RECRUITINGNANCT07436351ACT With CF Self-Help ToolkitThomas Jefferson University
- RECRUITINGNCT07083557Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)Bettina Mittendorfer
- RECRUITINGNCT07369414Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households: A Case-control Study of Exposure Risk at HomeResearch Center Borstel
- RECRUITINGNANCT07314229Prevalence of Exercise-induced Ventilatory Limitation and Associated Factors in Patients With Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-IvacaftorUniversity Hospital, Lille
- RECRUITINGNCT07505797ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)iSono Health, Inc.